ACE2 and COVID-19: In the pooled COVID-19 patients, ACE2 was expressed in several immune cells, such as dendritic cells, CD14 monocytes, CD4 memory T cells, CD4 naive T cells, CD8 effector T cells, etc.; TMPRSS2 was expressed in most immune cells (Figure 4b).